2022 Savings Offer for AJOVY is here. Learn more

Frequently asked questions

AJOVY for migraine in adults

AJOVY is indicated for the preventive treatment of migraine in adults and is the only anti-CGRP treatment with monthly 225 mg SC and quarterly 675 mg (225 mg x 3) SC dosing options.

See the efficacy results in clinical trials for AJOVY